PE121998A1 - Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida - Google Patents
Formulacion parenteral de dibenz(b,f)azepin-5-carboxamidaInfo
- Publication number
- PE121998A1 PE121998A1 PE1998000950A PE00095098A PE121998A1 PE 121998 A1 PE121998 A1 PE 121998A1 PE 1998000950 A PE1998000950 A PE 1998000950A PE 00095098 A PE00095098 A PE 00095098A PE 121998 A1 PE121998 A1 PE 121998A1
- Authority
- PE
- Peru
- Prior art keywords
- dibenz
- azepin
- carboxamide
- composition
- water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- ZFXVFMBOFIEPII-UHFFFAOYSA-N 1h-azepine-4-carboxamide Chemical compound NC(=O)C1=CC=CNC=C1 ZFXVFMBOFIEPII-UHFFFAOYSA-N 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 abstract 1
- 229960000623 carbamazepine Drugs 0.000 abstract 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000007951 isotonicity adjuster Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 229960001816 oxcarbazepine Drugs 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721497.7A GB9721497D0 (en) | 1997-10-09 | 1997-10-09 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE121998A1 true PE121998A1 (es) | 1999-12-08 |
Family
ID=10820342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000950A PE121998A1 (es) | 1997-10-09 | 1998-10-07 | Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6316417B1 (https=) |
| EP (1) | EP1033988B1 (https=) |
| JP (2) | JP2001519395A (https=) |
| KR (1) | KR100760326B1 (https=) |
| CN (1) | CN1210032C (https=) |
| AR (1) | AR015465A1 (https=) |
| AT (1) | ATE257383T1 (https=) |
| AU (1) | AU748034B2 (https=) |
| BR (1) | BR9812861A (https=) |
| CA (1) | CA2304661C (https=) |
| CO (2) | CO4950520A1 (https=) |
| CZ (1) | CZ298900B6 (https=) |
| DE (1) | DE69821024T2 (https=) |
| DK (1) | DK1033988T3 (https=) |
| ES (1) | ES2214738T3 (https=) |
| GB (1) | GB9721497D0 (https=) |
| HU (1) | HU226106B1 (https=) |
| ID (1) | ID24134A (https=) |
| IL (1) | IL135123A0 (https=) |
| MY (1) | MY122129A (https=) |
| NO (1) | NO327263B1 (https=) |
| NZ (1) | NZ503526A (https=) |
| PE (1) | PE121998A1 (https=) |
| PL (1) | PL192287B1 (https=) |
| PT (1) | PT1033988E (https=) |
| RU (1) | RU2242231C2 (https=) |
| SK (1) | SK286253B6 (https=) |
| TR (1) | TR200000870T2 (https=) |
| TW (1) | TW584563B (https=) |
| WO (1) | WO1999018966A1 (https=) |
| ZA (1) | ZA989183B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| US20100204178A1 (en) | 2006-10-02 | 2010-08-12 | James Cloyd | Novel parenteral carbamazepine formulation |
| PT1928464E (pt) * | 2005-09-30 | 2014-07-10 | Lundbeck Inc | Nova formulação parentérica de carbamazepina |
| WO2007092620A2 (en) * | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| US8372431B2 (en) * | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| CN101711739B (zh) * | 2008-10-08 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 卡马西平的口服药物组合物 |
| CN105726466A (zh) * | 2014-12-10 | 2016-07-06 | 辽宁药联制药有限公司 | 一种奥卡西平注射剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202311A (en) * | 1988-08-19 | 1993-04-13 | Children's Medical Center Corporation | Stabilized fgf composition |
| ATE133079T1 (de) * | 1989-12-27 | 1996-02-15 | Ciba Geigy Ag | Vorrichtung zum homogenisieren der inhomogenen lichtverteilung eines laserstrahllichtbündels |
| EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
| US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| RU2020972C1 (ru) * | 1991-02-07 | 1994-10-15 | Мегдятов Рашид Салехович | Способ лечения невралгии тройничного нерва |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
| FR2702148B1 (fr) | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US5466683A (en) | 1994-08-25 | 1995-11-14 | Teva Pharmaceutical Industries Ltd. | Water-soluble analogs of carbamazepine |
-
1997
- 1997-10-09 GB GBGB9721497.7A patent/GB9721497D0/en not_active Ceased
-
1998
- 1998-09-17 TW TW087115501A patent/TW584563B/zh not_active IP Right Cessation
- 1998-10-05 CO CO98057677A patent/CO4950520A1/es unknown
- 1998-10-05 CO CO98057677D patent/CO5090854A1/es unknown
- 1998-10-07 KR KR1020007003210A patent/KR100760326B1/ko not_active Expired - Fee Related
- 1998-10-07 EP EP98950110A patent/EP1033988B1/en not_active Expired - Lifetime
- 1998-10-07 SK SK505-2000A patent/SK286253B6/sk not_active IP Right Cessation
- 1998-10-07 WO PCT/EP1998/006382 patent/WO1999018966A1/en not_active Ceased
- 1998-10-07 PE PE1998000950A patent/PE121998A1/es not_active Application Discontinuation
- 1998-10-07 AU AU96298/98A patent/AU748034B2/en not_active Ceased
- 1998-10-07 CZ CZ20001279A patent/CZ298900B6/cs not_active IP Right Cessation
- 1998-10-07 ID IDW20000588A patent/ID24134A/id unknown
- 1998-10-07 RU RU2000110741/15A patent/RU2242231C2/ru not_active IP Right Cessation
- 1998-10-07 JP JP2000515601A patent/JP2001519395A/ja not_active Withdrawn
- 1998-10-07 NZ NZ503526A patent/NZ503526A/xx unknown
- 1998-10-07 PL PL339446A patent/PL192287B1/pl not_active IP Right Cessation
- 1998-10-07 CA CA002304661A patent/CA2304661C/en not_active Expired - Fee Related
- 1998-10-07 MY MYPI98004586A patent/MY122129A/en unknown
- 1998-10-07 HU HU0004362A patent/HU226106B1/hu not_active IP Right Cessation
- 1998-10-07 ES ES98950110T patent/ES2214738T3/es not_active Expired - Lifetime
- 1998-10-07 BR BR9812861-2A patent/BR9812861A/pt not_active Application Discontinuation
- 1998-10-07 PT PT98950110T patent/PT1033988E/pt unknown
- 1998-10-07 DE DE69821024T patent/DE69821024T2/de not_active Expired - Lifetime
- 1998-10-07 US US09/509,973 patent/US6316417B1/en not_active Expired - Fee Related
- 1998-10-07 CN CNB988099888A patent/CN1210032C/zh not_active Expired - Fee Related
- 1998-10-07 TR TR2000/00870T patent/TR200000870T2/xx unknown
- 1998-10-07 DK DK98950110T patent/DK1033988T3/da active
- 1998-10-07 AT AT98950110T patent/ATE257383T1/de not_active IP Right Cessation
- 1998-10-07 AR ARP980105003A patent/AR015465A1/es unknown
- 1998-10-07 IL IL13512398A patent/IL135123A0/xx unknown
- 1998-10-08 ZA ZA989183A patent/ZA989183B/xx unknown
-
2000
- 2000-04-04 NO NO20001730A patent/NO327263B1/no not_active IP Right Cessation
-
2001
- 2001-11-09 US US10/037,090 patent/US6458770B1/en not_active Expired - Fee Related
-
2005
- 2005-05-06 JP JP2005135218A patent/JP2005281314A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2131573T3 (es) | Procedimiento para el replegamiento de igf-i a una conformacion activa. | |
| BR0011205A (pt) | Dispositivo eletrônico orgânico flexível, display eletroluminescente, fotodetector e método de aperfeiçoamento da resistência à degradação do oxigênio e da umidade | |
| MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
| ES2190430T3 (es) | Nuevas sulfonamidas. | |
| BR9811927A (pt) | Dispositivo de liberação de agente benéfico propelido por gás que pode ser implantado | |
| ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
| CO4700491A1 (es) | Sistema transcorneal de liberacion de medicamentos | |
| AR026302A1 (es) | Un metodo para estabilizar solventes siliconados para la limpieza en seco, un adsorbente y un proceso de limpieza en seco. | |
| ES2194686T3 (es) | Banda de parachoques y parachoques provistos de dicha banda. | |
| BR9808895A (pt) | Partìcula de detergente | |
| PE121998A1 (es) | Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida | |
| DE50004443D1 (de) | Wirkstoffhaltige komposition sowie deren herstellung und verwendung | |
| ES2189121T3 (es) | Mezcla de estabilizantes para materiales organicos. | |
| AR036887A1 (es) | Dispositivo para liberacion de sustancias. | |
| BR9611343A (pt) | Processo de solubilização d eum agente em um anfifìlico, composição, e, uso da mesma. | |
| BR0308662A (pt) | Reservatório de substâncias semioquìmicas para atrair cupins subterrâneos que formam túneis no solo | |
| ES2054656T3 (es) | Poliesteres insaturados modificados y procedimiento para su preparacion. | |
| ES2169575T3 (es) | Soporte de datos con un estado fundamental reproducible de datos basicos y procedimiento para su realizacion. | |
| EA200200091A1 (ru) | Содержащая амброксол пастилка | |
| ES2104141T5 (es) | Dispositivo iontoforetico apto para ser activado por el usuario. | |
| ES2136724T3 (es) | Emulsion liofilizada, que contiene una sustancia activa. | |
| ES2040150T3 (es) | Reduccion de compuestos organicos halogenados en liquido de blanqueo gastado. | |
| ES2166219T3 (es) | Empleo de mezclas detergentes como solubilizantes. | |
| AR019724A2 (es) | Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas | |
| ATE263547T1 (de) | Pharmazeutische mischung, die ein profen und weitere aktivsubstanzen enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |